Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
DNA Research
Cost-effectiveness of human papillomavirus DNA testing assessed
August 18th, 2005
Investigators assessed the cost-effectiveness of human papillomavirus DNA testing in the United Kingdom, the Netherlands, France, and Italy. According to recent research from the United States, "European countries with established cytology-based screening programs for cervical cancer will soon face decisions about whether to incorporate human papillomavirus (HPV) DNA testing and what strategies will be most cost-effective." "We assessed the cost-effectiveness of incorporating HPV DNA testing into existing cervical cancer screening programs in the United Kingdom, the Netherlands, France, and Italy," explained J.J. Kim and colleagues, Harvard...
Source: Women's Health Weekly (2005-08-18)
|
